Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say
admin Merck & Co.’s roughly $40 billion deal for Seagen Inc. is unlikely to be finalized…
Read MoreSeagen
Merck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. MRK XE:MRK is in advanced talks to acquire Seagen Inc. SGEN and…
Read More